近日丹麦制药巨头诺和诺德公司董事会主席龙海歌在接受CGTN采访时高度赞扬中国政府在应对慢性病方面制定的明确目标和系统性规划如中国颁布的《“健康中国2030”规划纲要》。 他强调诺和诺德希望成为中国政府在医疗健康领域值得信赖的长期合作伙伴。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.